356-OR: Accuracy Evaluation of an Implantable CGM with Chemistry Improvements in a 365-Day Feasibility Study

• Published in: Diabetes (New York, N.Y.) Vol. 72; no. Supplement_1; p. 1
• Main Authors: AL-KHAWI, LUJAIN, SANCHEZ, PATRICIA, HUFFSTETLER, PHILIP, VELVADAPU, VENKATA N., MASCIOTTI, JAMES M., TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.
• Format: Journal Article
• Language: English
• Published: New York American Diabetes Association 20.06.2023
• Subjects: Diabetes mellitus; Feasibility studies

Background: The prospective, multi-center PROMISE study demonstrated safety and accuracy of the 180-day Eversense E3 CGM System in adults with diabetes. Subsequently, the implantable E3 CGM sensor material and protective chemistries were advanced to improve the sensor signal maintenance. This analys...